T0	Participants 15 77	chronic kidney disease with outcomes in chronic heart failure:
T1	Participants 189 222	patients with heart failure (HF).
T2	Participants 272 283	HF patients
T3	Participants 319 496	Of 7788 patients in the Digitalis Investigation Group trial, 3527 had CKD, defined by an estimated glomerular filtration rate (GFR) <60 ml/min/1.73 m(2) body surface area (BSA).
T4	Participants 1785 1820	ambulatory patients with chronic HF